A. El Akkaoui et al. / Tetrahedron 67 (2011) 7128e7138
7135
material (2 h), the reaction was cooled to room temperature,
quenched with water and extracted with dichloromethane
(2ꢂ15 mL). The combined organic layers were dried over magne-
sium sulfate and concentrated in vacuo. The resulting residue was
purified by column chromatography on silica gel (EtOAc/PE) to af-
ford the corresponding cross-coupling products 4, 5, 10e13.
128.6, 130.7, 132.7, 135.9, 143.1, 143.8, 145.0, 191.6. HRMS (EI) m/z
calcd for C20H13BrN2O [M]þ: 377.0289, found: 377.0274.
3.5. Procedure for Sonogashira cross-coupling reaction of
imidazo[1,2-a]pyridines (14 or 16)
Toasolution of6-bromo-3-iodoimidazo[1,2-a]pyridine (14 or 16)
(14: 100 mg or 16: 81 mg, 0.250 mmol) in 2 mL of a mixture of DMF/
Et3N (1/1, v/v) were successively added the desired alkyne
(0.501 mmol), copper iodide (0.050 mmol) and 8.7 mg (0.012 mmol)
of bis(triphenylphosphine)palladium dichloride. The reaction was
stirred at room temperature sealed under argon. Once TLC indicated
complete consumption of starting material (3 h), the reaction was
quenched with water and extracted with dichloromethane
(2ꢂ15 mL). The combined organic layer were dried over magnesium
sulfate and concentratedinvacuo. Theresulting residuewas purified
by column chromatography on silica gel (EtOAc/PE) to afford the
corresponding cross-coupling products 15, 17e20, and 22e24.
3.4.1. 3-Bromo-6-(3-methoxyphenyl)-2-phenylimidazo[1,2-a]pyri-
dine [4]. White solid, 90% yield, mp 127e128 ꢀC; IR (ATR)
n
(cmꢁ1) 1586, 1487, 1465, 1286, 825, 772, 718. 1H NMR (400 MHz,
CDCl3)
d
3.88 (s, 3H), 6.95 (dd, J¼8.1, 2.2 Hz, 1H), 7.10e7.14
(m, 1H), 7.19 (d, J¼7.7 Hz, 1H), 7.38e7.41 (m, 2H), 7.45e7.54
(m, 3H), 7.69 (d, J¼9.2 Hz, 1H), 8.11e8.17 (m, 2H), 8.33 (s, 1H). 13C
NMR (100.6 MHz, CDCl3)
d 55.5, 92.2, 113.2, 113.3, 117.5, 119.6,
121.4, 126.1, 127.7, 128.0, 128.5, 128.6, 130.4, 132.9, 138.7, 143.3,
144.9, 160.3. HRMS (EI) m/z calcd for C20H15BrN2O [M]þ:
379.0434, found: 379.0446.
3.4.2. 3,6-Bis-(3-methoxyphenyl)-2-phenylimidazo[1,2-a]pyridine
[5]. White solid, 19% yield, mp 140 ꢀC; IR (ATR)
n
(cmꢁ1) 1586, 1575,
3.5.1. 6-Bromo-3-(3-methoxyprop-1-ynyl)-2-phenylimidazo-[1,2-a]
1472, 1234, 1044, 776. 1H NMR (400 MHz, CDCl3)
d
3.80 (s, 3H), 3.86
pyridine [15]. Yellow solid, 90% yield, mp 95 ꢀC; IR (ATR) (cmꢁ1
n )
(s, 3H), 6.91 (dd, J¼8.1, 2.1 Hz, 1H), 7.00e7.06 (m, 3H), 7.07e7.09 (m,
2H), 7.25e7.27 (m, 1H), 7.28e7.33 (m, 2H), 7.36 (t, J¼7.9 Hz, 1H),
7.44e7.47 (m, 1H), 7.48 (d, J¼4.2 Hz, 1H), 7.70e7.72 (m, 2H), 7.74 (d,
3057, 2923, 2360, 1516, 1492, 1492, 1088, 820, 796, 687. 1H NMR
(400 MHz, CDCl3)
d
3.52 (s, 3H), 4.54 (s, 2H), 7.31 (dd, J¼9.4, 1.8 Hz,
1H), 7.36e7.41 (m, 1H), 7.44e7.48 (m, 2H), 7.51 (d, J¼9.2 Hz, 1H),
J¼9.3 Hz, 1H), 8.12 (s, 1H). 13C NMR (100.6 MHz, CDCl3)
d 55.5, 112.8,
8.25e8.26 (m, 2H), 8.39 (d, J¼1.1 Hz, 1H). 13C NMR (100.6 MHz,
113.3, 114.9, 116.1, 117.4, 119.5, 120.8, 121.4, 123.0, 125.5, 126.8, 127.6,
128.1, 128.4, 130.2, 130.8, 131.2, 134.2, 139.2, 143.0, 144.2, 160.2,
160.6. HRMS (EI) m/z calcd for C27H22N2O2 [MþH]þ: 407.1760,
found: 407.1751.
CDCl3) d 58.0, 60.7, 75.0, 98.3, 104.3, 107.9, 118.1, 125.2, 127.3, 128.6,
128.9, 129.8, 143.6, 143.6, 149.0. HRMS (EI) m/z calcd for
C17H13BrN2O [M]þ: 341.0289, found: 341.0270.
3.5.2. 6-Bromo-3-(3-methoxyprop-1-ynyl)imidazo[1,2-a]pyridine
3.4.3. 3-Bromo-6-(4-methoxyphenyl)-2-phenylimidazo[1,2-a]pyri-
[17]. Yellow solid, 96% yield, mp 76 ꢀC; IR (ATR) (cmꢁ1) 3063,
n
dine [10]. White solid, 88% yield, mp 198 ꢀC; IR (ATR)
n
(cmꢁ1) 2998,
2208, 1479, 1310, 1088, 902, 753. 1H NMR (400 MHz, CDCl3)
d 3.49
1605, 1512, 1439, 1245, 813, 735, 700. 1H NMR (400 MHz, CDCl3)
(s, 3H), 4.47 (s, 2H), 7.33 (dd, J¼9.6, 1.8 Hz, 1H), 7.55 (d, J¼9.6 Hz,
d
3.86 (s, 3H), 7.01 (d, J¼8.7 Hz, 2H), 7.39 (t, J¼7.3 Hz, 1H), 7.46e7.48
1H), 7.83 (s, 1H), 8.415e8.419 (m, 1H). 13C NMR (100.6 MHz, CDCl3)
(m, 3H), 7.52 (d, J¼8.7 Hz, 2H), 7.66 (d, J¼9.2 Hz, 1H), 8.14 (d,
d 57.9, 60.5, 73.2, 96.1,108.2,118.6,125.3,129.2,139.2. HRMS (EI) m/z
J¼7.7 Hz, 2H), 8.24e8.28 (m, 1H). 13C NMR (100.6 MHz, CDCl3)
calcd for C11H10BrN2O [MþH]þ: 264.9971, found: 264.9971.
d
55.5, 92.0, 114.7, 117.4, 120.6, 126.0, 127.4, 127.9, 128.2, 128.4, 128.5,
129.6, 133.0, 143.1, 144.7, 159.8. HRMS (EI) m/z calcd for
3.5.3. 4-(6-Bromoimidazo[1,2-a]pyridin-6-yl)-2-methylbut-3-yn-2-
C20H15BrN2O [M]þ: 379.0438, found: 379.0446.
ol [18]. Yellow solid, 95% yield, mp 129 ꢀC; IR (ATR) (cmꢁ1) 3206,
n
2980, 1487, 1154, 802, 690. 1H NMR (400 MHz, CDCl3)
d 1.71 (s, 6H),
3.4.4. 3-Bromo-6-(m-tolyl)-2-phenylimidazo[1,2-a]pyridine
7.32 (dd, J¼9.2, 1.6 Hz, 1H), 7.54 (d, J¼9.2 Hz, 1H), 7.79 (s, 1H), 8.32
[11]. Yellow solid, 87% yield, mp 71 ꢀC; IR (ATR)
n
(cmꢁ1) 3062,
(dd, J¼1.6, 0.8 Hz,1H). 13C NMR (100.6 MHz, CDCl3)
d 31.6, 66.1, 69.2,
2919, 1673, 1466, 1439, 1211, 826, 730, 680. 1H NMR (400 MHz,
CDCl3) 2.41 (s, 3H), 7.21e7.24 (m, 1H), 7.37e7.40 (m, 4H),
104.8, 108.2, 118.7, 125.2, 129.2, 138.7. HRMS (EI) m/z calcd for
d
C12H12BrN2O [MþH]þ: 279.0128, found: 279.0127.
7.43e7.50 (m, 3H), 7.66 (d, J¼9.2 Hz, 1H), 8.06e8.17 (m, 2H), 8.27 (d,
J¼0.7 Hz, 1H). 13C NMR (100.6 MHz, CDCl3)
d
21.6, 92.1, 117.5, 121.2,
3.5.4. 3-(6-Bromoimidazo[1,2-a]pyridin-6-yl)-prop-2-yn-1-ol
124.2, 126.1, 127.8, 127.9, 128.4, 128.5, 128.9, 129.1, 133.0, 137.1, 139.0,
143.2, 144.9. HRMS (EI) m/z calcd for C20H15BrN2 [M]þ: 363.0497,
found: 363.0498.
[19]. Yellow solid, 92% yield, mp 154 ꢀC; IR (ATR) (cmꢁ1) 3180,
n
3063, 2208,1479, 1080, 690. 1H NMR (400 MHz, DMSO-d6)
d 4.46 (d,
J¼6.0 Hz, 2H), 5.45 (t, J¼6.0 Hz, 1H), 7.51 (dd, J¼9.6, 2.0 Hz, 1H), 7.67
(d, J¼9.6 Hz, 1H), 7.91 (s, 1H), 8.68 (s, 1H). 13C NMR (100.6 MHz,
3.4.5. 3-Bromo-2-phenyl-6-(thiophen-3-yl)imidazo[1,2-a]pyridine
DMSO-d6) d 49.8, 70.6, 100.7, 107.7, 118.5, 125.3, 129.1, 138.0. HRMS
[12]. Yellow solid, 90% yield, mp 191 ꢀC; IR (ATR)
n
(cmꢁ1) 1467,1426,
(EI) m/z calcd for C10H8BrN2O [MþH]þ: 250.9815, found: 250.9812.
1145, 775, 766, 693. 1H NMR (400 MHz, CDCl3)
7.46e7.53 (m, 5H), 7.66 (dd, J¼9.2, 0.7 Hz,1H), 8.13e8.16 (m), 8.35 (s,
1H). 13C NMR (100.6 MHz, CDCl3)
92.2, 117.7, 120.6, 121.3, 122.7,
d 7.38e7.43 (m, 2H),
3.5.5. 6-Bromo-3-(phenylethynyl)imidazo[1,2-a]pyridine
d
[20]. Yellow solid, 96% yield, mp 122 ꢀC; IR (ATR) (cmꢁ1) 3059,
n
125.5, 125.9, 127.3, 127.9, 128.4, 128.6, 132.9, 138.0, 143.2, 144.8.
HRMS (EI) m/z calcd for C17H11BrN2S [M]þ: 354.9905, found:
354.9889.
2208, 1473, 1240, 684. 1H NMR (400 MHz, CDCl3)
d
7.34 (dd, J¼15.2,
2.8 Hz, 1H), 7.39e7.43 (m, 3H), 7.55 (s, 1H), 7.58e7.61 (m, 2H), 7.89
(s, 1H), 8.47 (d, J¼2.0 Hz, 1H). 13C NMR (100.6 MHz, CDCl3)
d 75.8,
99.8, 108.3, 118.8, 122.3, 125.5, 128.7, 129.1, 129.2, 131.6, 138.8. HRMS
3.4.6. 4-(3-Bromo-2-phenylimidazo[1,2-a]pyridin-6-yl)benzalde-
(EI) m/z calcd for C15H10BrN2 [MþH]þ: 297.0022, found: 297.0025.
hyde [13]. Yellow solid, 85% yield, mp 192 ꢀC; IR (ATR)
n )
(cmꢁ1
2780, 1700, 1601, 1469, 1213, 815, 771, 695. 1H NMR (400 MHz,
CDCl3)
3.5.6. 3-(6-Bromo-2-phenylimidazo[1,2-a]pyridin-6-yl)-prop-2-yn-
d
7.41 (t, J¼7.3 Hz, 1H), 7.50 (t, J¼7.5 Hz, 2H), 7.56 (dd, J¼9.3,
1-ol [22]. White solid, 88% yield, mp 211 ꢀC; IR (ATR) (cmꢁ1) 3183,
n
1.7 Hz, 1H), 7.75 (d, J¼9.2 Hz, 1H), 7.80 (d, J¼8.1 Hz, 2H), 8.02 (d,
3082, 2972, 2360, 1491, 1088, 682. 1H NMR (400 MHz, DMSO-d6)
4.57 (d, J¼6.0 Hz, 2H), 5.55 (t, J¼6.0 Hz, 1H), 7.39e7.45 (m, 1H),
7.51 (t, J¼7.5 Hz, 2H), 7.55 (dd, J¼9.4, 1.9 Hz, 1H), 7.68 (d, J¼9.4 Hz,
J¼8.1 Hz, 2H), 8.13e8.19 (m, 2H), 8.42 (s, 1H), 10.10 (s, 1H). 13C NMR
d
(100.6 MHz, CDCl3)
d 92.6, 118.0, 122.0, 125.3, 126.4, 127.7, 128.0,